The SAA test, introduced by the Michael J. Fox Foundation, marks a pivotal advancement in Parkinson's disease research by detecting the earliest signs of the disease through the presence of misfolded alpha-synuclein in spinal fluid. This test offers hope for early diagnosis and treatment, potentially transforming the care and management of Parkinson’s disease.

Basic information

Country

USA

Group Name

Michael J. Fox Foundation

Source

Source